Unlocking Drug Discovery with Advanced Affinity Selection-Mass Spectrometry Techniques
Explore how AS-MS technology enhances protein-ligand binding studies, enabling the discovery of orthosteric, allosteric, and cip ligands. With over 22 years of experience, we leverage unique binding conditions to analyze diverse ligands and biologics, facilitating breakthroughs in drug discovery and development.
5/8/20241 min read
Protein-ligand binding